New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
The Clorox Company
CLX
Shape
US Flag

NYSE

19B

Household & Personal Products

Next Earning date - 30 Oct 2024

19B

Household & Personal Products

Next Earning date - 30 Oct 2024

156.69USD
Shape-2.29 ( -1.44%)
favorite-chart

Relative Strenght

9
favorite-chart

Volume Buzz

-14%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

7%

Quote Panel

Shape
Updated October 27, 2024
1W -1.55 % 1M -3.07 % 3M 18.03 % 1Y 37.88 %

Key Metrics

Shape
  • Market Cap

    19.38B


  • Shares Outstanding

    123.67M


  • Share in Float

    123.29M


  • Dividende

    4.88


  • Earning Date

    30 Oct 2024


  • Price Target

    156.69


  • Average Volume

    1.21M


  • Beta

    0.394


  • Range

    114.69-169.09


  • Industry

    Household & Personal Products


  • Website

    https://www.thecloroxcompany.com


  • Sector

    Consumer Defensive


Fundamentals

Shape

25.35x

P/E Ratio

2.73x

P/S Ratio

59.38x

P/B Ratio

9.4

Debt/Equity

3.9%

Net Margin

$2.3

EPS

How CLX compares to sector?

P/E Ratio

Relative Strength

Shape

CLX

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$7B

Shape267%

2025-Revenue

$5.54

Shape219%

2025-EPS

$1B

Shape172%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Jefferies

upgrade

Previous: Hold

2024-10-01

Now: Buy

Cowen & Co.

initialise

Previous: Sell

2024-07-22

Now: Buy

Cowen & Co.

initialise

Previous: Not converted

2024-07-22

Now: Sell

Exane BNP Paribas

initialise

Previous: Not converted

2024-06-24

Now: Underperform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-23%

0.93
vs 1.21

Q4.22

arrow
arrow

+48%

0.98
vs 0.66

Q1.23

arrow
arrow

+15%

1.51
vs 1.31

Q2.23

arrow
arrow

+80%

1.67
vs 0.93

Q3.23

arrow
arrow

-47%

0.49
vs 0.93

Q4.23

arrow
arrow

+120%

2.16
vs 0.98

Q1.24

arrow
arrow

+13%

1.71
vs 1.51

Q2.24

arrow
arrow

+9%

1.82
vs 1.67

Q3.24

arrow
arrow

+184%

1.39
vs 0.49

Q4.24

arrow
arrow

-30%

1.51
vs 2.16

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-4%

1.7B  vs 1.8B

Q4.22

arrow
arrow

+1%

1.7B  vs 1.7B

Q1.23

arrow
arrow

+6%

1.9B  vs 1.8B

Q2.23

arrow
arrow

+12%

2B  vs 1.8B

Q3.23

arrow
arrow

-20%

1.4B  vs 1.7B

Q4.23

arrow
arrow

+16%

2B  vs 1.7B

Q1.24

arrow
arrow

-5%

1.8B  vs 1.9B

Q2.24

arrow
arrow

-6%

1.9B  vs 2B

Q3.24

arrow
arrow

+18%

1.6B  vs 1.4B

Q4.24

arrow
arrow

-17%

1.6B  vs 2B

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+26%

0.26
vs 0.18

Q4.22

arrow
arrow

+31%

0.31
vs 0.26

Q1.23

arrow
arrow

-6967%

-69.67
vs 0.31

Q2.23

arrow
arrow

+80%

0.8
vs -69.67

Q3.23

arrow
arrow

-59%

-0.59
vs 0.8

Q4.23

arrow
arrow

+175%

1.75
vs -0.59

Q1.24

arrow
arrow

-56%

-0.56
vs 1.75

Q2.24

arrow
arrow

+66%

0.66
vs -0.56

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

1071

1.1K
vs 1.1K

-4%

Q4.22

arrow
arrow

1138

1.1K
vs 1.1K

6%

Q1.23

arrow
arrow

1161

1.2K
vs 1.1K

2%

Q2.23

arrow
arrow

1163

1.2K
vs 1.2K

0%

Q3.23

arrow
arrow

1094

1.1K
vs 1.2K

-6%

Q4.23

arrow
arrow

1146

1.1K
vs 1.1K

5%

Q1.24

arrow
arrow

1176

1.2K
vs 1.1K

3%

Q2.24

arrow
arrow

1100

1.1K
vs 1.2K

-6%

Earnings Growth

Latest News